🔎 Trials Near Me

Beranda › Penyakit Alzheimer › Florida › Orlando

Uji klinis Penyakit Alzheimer di Orlando, FL

25 studi untuk Penyakit Alzheimer mencari peserta di lokasi sekitar Orlando (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

Menerima pesertaFase 2
  • Clinical Site, Orlando
Usia 55 hingga 90 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06887192

A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

Menerima pesertaFase 2
  • K2 Medical Research, Maitland · 6 mi jauhnya
Usia 55 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT06540833

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

Menerima pesertaFase 3
  • Local Institution - 1635, Orlando
Usia 55 hingga 90 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06937229

A Study of LY3439539 in Participants With Alzheimer's Disease

Menerima pesertaFase 1
  • Charter Research, Orlando
  • AdventHealth Orlando, Orlando
  • K2 Medical Research, Maitland · 6 mi jauhnya
Usia 50 hingga 85 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT07598370

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

Menerima pesertaFase 3
  • Charter Research Orlando, Orlando
  • Nova Psychiatry, Orlando
  • Combined Research Orlando Phase I-IV LLC, Orlando
  • dan 1 lainnya
Usia 55 hingga 90 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06585787

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

Menerima pesertaFase 2
  • Charter Research - Orlando, Orlando
  • Conquest Research, Winter Park · 5 mi jauhnya
  • K2 Medical Research ORLANDO, Maitland · 6 mi jauhnya
Usia 55 hingga 85 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07589595

Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

Menerima pesertaFase 2
  • Conquest Research - Lake Nona, Orlando
Usia 55 hingga 80 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06847321

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Menerima pesertaFase 3
  • Charter Research - Winter Park/Orlando, Orlando
  • Conquest Research - Lake Nona, Orlando
  • Conquest Research, LLC, Winter Park · 5 mi jauhnya
  • dan 2 lainnya
Usia 50 hingga 90 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07177352

A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease

Menerima pesertaFase 1/2
  • Conquest Research - Winter Park /ID# 277760, Winter Park · 5 mi jauhnya
  • K2 Medical Research - Clermont /ID# 277859, Clermont · 24 mi jauhnya
Usia 50 hingga 90 · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07599670

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

Menerima pesertaFase 3
  • Combined Research Orlando (CRO), Orlando
  • Local Institution - 1622, Maitland · 6 mi jauhnya
  • Local Institution - 1631, Maitland · 6 mi jauhnya
Usia 55 hingga 90 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07011732

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

Menerima pesertaFase 3
  • Local Institution - 2634, Orlando
Usia 55 hingga 90 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07011745

A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease

Menerima pesertaFase 3
  • K2 Medical Research, LLC, Maitland · 6 mi jauhnya
Usia 55 hingga 80 · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT07717411

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

Menerima pesertaFase 2
  • ClinCloud, Maitland · 6 mi jauhnya
  • Local Institution - 0007, Maitland · 6 mi jauhnya
Usia 55 hingga 90 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT06808984

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

Menerima pesertaFase 2
  • Charter Research - Orlando ( Site 1051), Orlando
  • Conquest Research LLC ( Site 1053), Winter Park · 5 mi jauhnya
  • K2 Medical Research ( Site 1047), Maitland · 6 mi jauhnya
Usia 50 hingga 85 · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT07033494

A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

Menerima pesertaFase 1
  • K2 Medical Research, LLC, Maitland · 6 mi jauhnya
Usia 50 hingga 85 · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT06297590

A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)

Menerima pesertaFase 1/2
  • Charter Research, LLC, Orlando
  • Headlands Horizons LLC, Orlando
Usia 35 hingga 85 · Semua jenis kelamin · Diperbarui 10 Jul 2026 · NCT05462106

Low-Dose Radiotherapy for Alzheimer's Disease

Menerima pesertaFase 1/2
  • Renaissance Institute of Precision Oncology & Radiosurgery, Winter Park · 5 mi jauhnya
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 9 Jul 2026 · NCT07693140

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

Menerima pesertaFase 3
  • Charter Research - Orlando, Orlando
  • Headlands Research Orlando, Orlando
  • Conquest Research, Winter Park · 5 mi jauhnya
  • dan 1 lainnya
Usia 55 ke atas · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT07602582

A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

Menerima pesertaFase 2
  • Conquest Research, Winter Park · 5 mi jauhnya
  • K2 Medical Research LLC, Maitland · 6 mi jauhnya
  • K2 Medical Research LLC, Maitland · 6 mi jauhnya
Usia 50 hingga 85 · Semua jenis kelamin · Diperbarui 26 Jun 2026 · NCT07094516

A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)

Menerima pesertaFase 1Sukarelawan sehat diterima
  • K2 Medical Research, Maitland · 6 mi jauhnya
Usia 45 hingga 85 · Semua jenis kelamin · Diperbarui 4 Jun 2026 · NCT06657768

[18F]PI-2620 Phase 3 Histopathological Study

Menerima pesertaFase 3
  • Charter Research, Winter Park · 5 mi jauhnya
  • K2 Medical Research, Maitland · 6 mi jauhnya
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 22 Mei 2026 · NCT05641688

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Charter Research, Orlando
  • Conquest Research, Winter Park · 5 mi jauhnya
  • K2 Medical Research, Maitland · 6 mi jauhnya
  • dan 1 lainnya
Usia 60 hingga 90 · Semua jenis kelamin · Diperbarui 15 Apr 2026 · NCT06584357

Open-label Extension Study in Participants With Early Alzheimer's Disease

Menerima pesertaFase 2
  • GSK Investigational Site, Maitland · 6 mi jauhnya
Usia 50 hingga 85 · Semua jenis kelamin · Diperbarui 2 Feb 2026 · NCT07105709

ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease

Menerima peserta
  • Advent Health, Orlando
Usia 50 hingga 85 · Semua jenis kelamin · Diperbarui 9 Jan 2026 · NCT03671889

University of Central Florida CereBank

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • University of Central Florida, Orlando
Usia 18 ke atas · Wanita · Diperbarui 14 Mar 2025 · NCT06876857

Uji klinis Penyakit Alzheimer di kota lain

Studi lain di Orlando

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.